Opinion
4:21-cv-05990-HSG
12-06-2021
SOPHIE HU and FUMIAN ZHAO, Plaintiffs, v. JANSSEN PHARMACEUTICALS INC. JOHNSON AND JOHNSON; BAYER HEALTHCARE PHARMACEUTICALS INC BAYER CORPORATION Defendants.
ORDER GRANTING DEFENDANTS JANSSEN PHARMACEUTICALS, INC. AND BAYER HEALTHCARE PHARMACEUTICALS INC.'S ADMINISTRATIVE MOTION TO CONTINUE DECEMBER 14, 2021 CASE MANAGEMENT CONFERENCE UNTIL JPML RULING ON MOTION TO TRANSFER ACTION TO MDL 2592 (AS MODIFIED)
Haywood S. Gilliam, Jr., United States District Judge
This matter is before the Court on Defendants Janssen Pharmaceuticals, Inc. (“Janssen”) and Bayer HealthCare Pharmaceuticals Inc.'s (“Bayer”) Administrative Motion To Continue December 14, 2021 Case Management Conference Until JPML Ruling on Motion to Transfer Action to MDL 2592. Having reviewed the parties' submissions, and upon consideration of all the files, records, and proceedings in this matter and finding good cause shown, IT IS HEREBY ORDERED that the December 14, 2021 Case Management Conference is continued to January 4, 2022 at 2:00 p.m. The case management conference will be held telephonically. Pro se plaintiffs and all counsel shall use the following dial-in information to access the call: Dial-In: 888-808-6929/Passcode: 6064255. Accordingly, the December 7, 2021 deadline for the parties to submit Case Management Statements is vacated and continued to December 28, 2021.